Search clinical trials for: Thalidomide(Thado)

Total 434 results

University of Miami

Completed

Long-Term Followup and/or Thalidomide Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165

Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma

United States
Merck Sharp & Dohme LLC
Novartis Pharmaceuticals

Completed

A Study of the Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With Trametinib and Dabrafenib in Participants With Advanced Melanoma (MK-3475-022/KEYNOTE-022)

Melanoma | Solid Tumors
National Institute of Allergy and Infectious Diseases...
Andrulis Pharmaceuticals

Completed

Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection

HIV Infections | Stomatitis, Aphthous

United States, Puerto Rico
M.D. Anderson Cancer Center
Celgene Corporation

Completed

The Effects of Thalidomide on Symptom Clusters

Advanced Cancers

United States
Zhizheng Ge

Withdrawn

Retreatment and Its Efficiency of Thalidomide for Vascular Malformation Patients With Failure of First Course Treatment

Gastrointestinal Bleeding of Unknown Origin | Gastrointestinal Vascular Malformation | Thalidomide Efficiency

China
National Cancer Institute (NCI)
Gynecologic Oncology Group

Completed

Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Fallopian Tube Cancer | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer

United States
Celgene Corporation

Completed

A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma

Multiple Myeloma

United States, Spain, Australia, Canada, United Kingdom, Italy, Switzerland, Bulgaria, Poland, Ukraine, Belgium, Germany, Hungary, Ireland, Israel, Russian Federation
FDA Office of Orphan Products Development

Completed

Risk-adapted Therapy for Primary Systemic (AL) Amyloidosis

Amyloidosis
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis

Multiple Myeloma and Plasma Cell Neoplasm

United States
University of Arkansas

Withdrawn

A Pilot Study of the Combination of Melphalan, Bortezomib, Thalidomide and Dexamethasone (MEL-VTD)

Multiple Myeloma

United States
Grupo de Estudos Multicentricos em Onco-Hematologia

Completed

Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma

Multiple Myeloma

Brazil
Intergroupe Francophone du Myelome

Unknown

Study in Myeloma Patients Newly Diagnosed Treated as an Induction With Velcade-Dex or Velcade (Bortezomib) Thalidomide Dexamethasone (VTD)

Multiple Myeloma

France, Belgium
Children's Hospital of Fudan University

Not yet recruiting

Thalidomide Therapy for VEOIBD

Inflammatory Bowel Diseases
M.D. Anderson Cancer Center
Celgene

Completed

Preoperative Thalidomide Followed By Radical Retropubic Prostatectomy In Select Patients With Locally Advanced Prostate Cancer

Prostate Cancer

United States
Fujian Cancer Hospital

Unknown

EGFR Mutation Positive NSCLC Patients With Gefitinib and Thalidomide

Chemotherapy Effect | NSCLC Stage IV

China
Banner Health

Unknown

Thalidomide for Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States
Mayo Clinic
Celgene Corporation

Terminated

Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC)

Primary Sclerosing Cholangitis

United States
National Cancer Institute (NCI)

Completed

A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus

Discoid Lupus Erythematosus

United States
Rockefeller University

Completed

A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAART

HIV Infections

United States
Nanfang Hospital of Southern Medical University

Recruiting

Thalidomide Maintenance Treatment in DLBCL

Lymphoma, Large B-Cell, Diffuse

China
University of North Carolina, Chapel Hill
Celgene Corporation

Terminated

Open Label of Thalidomide in Treatment of Women With Chronic Pelvic Pain Associated With Endometriosis

Endometriosis

United States
Gruppo Italiano per lo Studio del Mieloma Multiplo

Completed

Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients

Multiple Myeloma

Italy
University Hospital, Caen
Laphal

Completed

Multiple Myeloma Treated With Thalidomide Before Autotransplant or With Conventional Chemotherapy and as Consolidation/Maintenance Treatment in Young and Elderly Patients : 3 Randomized Studies. (MAG 2002)

Multiple Myeloma de Novo Treatment

France
Shenzhen Fifth People's Hospital

Unknown

The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol

Cancer, Therapy-Related
National Cancer Institute (NCI)

Terminated

Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer

Lung Cancer

United States, South Africa
Austrian Forum Against Cancer

Completed

Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A vs Intron A for Maintenance Therapy

Multiple Myeloma

Austria
Fox Chase Cancer Center
National Cancer Institute (NCI)

Withdrawn

Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer

Kidney Cancer
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Completed

Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Unknown

Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
SCRI Development Innovations, LLC
CTI BioPharma

Completed

Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma

Multiple Myeloma
National Cancer Institute (NCI)
Gynecologic Oncology Group

Completed

Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Recurrent Uterine Corpus Sarcoma | Uterine Corpus Leiomyosarcoma

United States
Xiao-Lin Yin

Unknown

The Effective and Safety of Thalidomide in TI

Thalassemia

China
Xiao-Lin Yin

Unknown

The Effective and Safety of Thalidomide in NTDT

Thalassemia

China
Celgene

Completed

Study to Evaluate Pharmacokinetics of Pomalidomide in Hepatically Impaired Males

Clinical Pharmacology, Healthy Volunteer Study

United States
First Affiliated Hospital, Sun Yat-Sen University

Completed

Thalidomide in Treating Crohn's Disease

Crohn's Disease

China
University Hospital, Lille

Completed

Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma

Multiple Myeloma

France
George A. Kaysen, M.D.
Beth Israel Medical Center

Terminated

The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis Patients (ICM)

Hypoalbuminemia

United States
Peking Union Medical College Hospital

Recruiting

Thalidomide, Cyclophosphamide and Dexamethasone for Recurrent/Refractory Adult Langerhans Cell Histiocytosis

Langerhans Cell Histiocytosis

China
Intergroupe Francophone du Myelome

Completed

Pharmacogenomic Study in Myeloma Patients Treated With Melphalan-prednisone-thalidomide or Lenalidomide-dexamethasone

Myeloma

France
Nantes University Hospital

Completed

Efficacy Study Comparing Velcade Dexamethasone Thalidomide Versus Velcade Cyclophosphamide Dexamethasone as Induction Treatment in the Initial Management of Multiple Myeloma (IFM2013-04) (IFM2013-04)

Multiple Myeloma

France
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
University of Arkansas

Completed

Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide

Multiple Myeloma

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Helsinki University Central Hospital
Turku University Hospital; Oulu University Hospital; Kuopio University Hospital; Tampere University Hospital

Completed

ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors

Brainstem Glioma

Finland
Celgene

Completed

A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors

Central Nervous System Neoplasms | Medulloblastoma

United States, Italy, France, Spain, United Kingdom
Zhejiang Cancer Hospital

Unknown

Thalidomide Plus Chemotherapy Versus Chemotherapy Alone for Advanced Breast Cancer

Metastatic Breast Cancer

China
Korean Multiple Myeloma Working Party
Celgene Corporation

Unknown

TCD Followed by autoSCT for Newly Diagnosed MM Patients

Multiple Myeloma

Korea, Republic of
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis

Multiple Myeloma | Plasma Cell Myeloma

United States
Grupo de Estudos Multicentricos em Onco-Hematologia

Completed

Superiority of VCD Versus CTD in Patients With Newly Diagnose Multiple Myeloma Eligible for Transplantation (GBRAM003r)

Multiple Myeloma | Effects of Chemotherapy

Search clinical trials for: Thalidomide(Thado)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations